Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Natrol Secures Rights to New Form of NADH - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Natrol Secures Rights to New Form of NADH

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Natrol Secures Rights to New Form of NADH
Natrol, Inc., Chatsworth, CA, has entered into an exclusive patent li­censing agreement with Austria-based Oekopharm GmbH for the manufacture, sales, distribution and marketing of nicotinamide adenine dinucleotide hydride (NADH) in North America. The unique patent pending technology stabilizes NADH, which helps promote optimal absorption and assure a long, effective shelf life. Also known as coenzyme 1, NADH is a highly specialized form of the B vitamin niacin, which is found in all living cells and plays a key role in energy production and neurotransmitter processes.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters